Attached files
| file | filename |
|---|---|
| EX-32.3 - CERTIFICATION - Celularity Inc | f10k2020a1ex32-3_gxacqu.htm |
| EX-32.1 - CERTIFICATION - Celularity Inc | f10k2020a1ex32-1_gxacqu.htm |
| EX-31.3 - CERTIFICATION - Celularity Inc | f10k2020a1ex31-3_gxacqu.htm |
| EX-31.2 - CERTIFICATION - Celularity Inc | f10k2020a1ex31-2_gxacqu.htm |
| EX-31.1 - CERTIFICATION - Celularity Inc | f10k2020a1ex31-1_gxacqu.htm |
| 10-K/A - AMENDMENT NO. 1 TO FORM 10-K - Celularity Inc | f10k2020a1_gxacquisition.htm |
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Amendment No. 1 to the Annual Report of GX Acquisition Corp. (the “Company”) on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Dean C. Kehler, co-Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:
| 1. | The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company. |
| Date: May 24, 2021 | /s/ Dean C. Kehler |
| Dean C. Kehler | |
| co-Chief Executive Officer | |
| (co-Principal Executive Officer) |